Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: Scott H. Davis who wrote (2448)	2/3/1999 1:42:00 AM
From: Larry Liebman	Read Replies (1) \| Respond to of 4676

Spoke with IR at ISIP. They mentioned that there had been an interim "select" view of Crohn's data, and that it remained positive, with the trial continuing to progress. In addition, Novartis cancer-trials, remain on track, after re-tests to "validate" data falsified by a Novartis employee.

To: Scott H. Davis who wrote (2448)	2/5/1999 11:36:00 PM
From: Greg Rich	Respond to of 4676

Did you ever get a response on your email? I don't think we will ever be invited to actively participate in conference calls. I suspect the annual stockholder's meeting is the one and only chance any of us truly have at the big guys in the company. I suppose I'd pay more attention to folks that had millions to invest as well. We'll just have to keep prospecting for our information and sharing any we find with one another, at least till antisense makes us millionaires as well. Greg